Jin Zhou
Harbin Medical University
3 Papers
11 Citations
Jin Zhou is an academic researcher from Harbin Medical University. The author has contributed to research in topics: Terra incognita & Host (biology). The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Epidemiology and treatment of invasive fungal diseases in patients with multiple myeloma: findings from a multicenter prospective study from China.
Junru Liu,He Huang,Yan Li,Lin Liu,Jianyong Li,Zhuogang Liu,Jin Lu,Jian Ouyang,Yongping Song,Daobin Zhou,Hanyun Ren,Jun Ma,Chun Wang,Li Yu,Jin Zhou,Jianmin Wang,Yang Xiao,Xiao-Jun Huang,Juan Li +18 more
TL;DR: The present multicenter study suggests that the incidence of IFD per chemotherapy courses in MM patients is 3.8 % and most patients are labelled as having possible IFD.
11
A Meloidogyne incognita effector Minc03329 suppresses plant immunity and promotes parasitism
Jin Zhou,Xiaoping Zhang,Ruiqiang Li,Jian Ling,Yan Li,Yuhong Yang,Bingyan Xie,Jianlong Zhao,Zhenchuan Mao +8 more
TL;DR: In this paper , the authors characterized a new effector, Minc03329, which contains signal peptide for secretion and a C-type lectin domain, and showed that Minc-03329 is an important effector for M. incognita, suppressing host defense response and promoting pathogenicity.
2
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
Yue-Yun Lai,Xiao-Jun Huang,Juan Li,Ping Zou,Zefeng Xu,Hui Sun,Zong-Hong Shao,Daobin Zhou,Fangping Chen,Zhuogang Liu,Huanling Zhu,Depei Wu,Chun Wang,Yin Zhang,Yan Li,Ming Hou,Xin Du,Xin Wang,Wei Li,Yongrong Lai,Jin Zhou,Yu-hong Zhou,Mei-Yun Fang,Lin Qiu,Xiaomin Wang,Guang-sen Zhang,Ming Jiang,Yingmin Liang,Lian-Sheng Zhang,Xie-Qun Chen,Hai Bai,Jin-Ying Lin +31 more
TL;DR: The multicenter studies emphasised and confirmed the importance of applying standardized FISH testing based on an appropriate panel of probes to detect common cytogenetic abnormalities in Chinese de novo MDS patients, particularly those with normal or failed CC results.